Case Report: Post-traumatic splenosis and potential pitfall for PSMA-PET.

18F-PSMA PET/CT 99mTc-sulphur colloid SPECT ectopic splenic tissue false positive prostate cancer splenosis

Journal

Frontiers in nuclear medicine (Lausanne, Switzerland)
ISSN: 2673-8880
Titre abrégé: Front Nucl Med
Pays: Switzerland
ID NLM: 9918470388806676

Informations de publication

Date de publication:
2023
Historique:
received: 11 10 2023
accepted: 08 11 2023
medline: 2 10 2024
pubmed: 2 10 2024
entrez: 2 10 2024
Statut: epublish

Résumé

18F-prostate specific membrane antigen (PSMA) PET is fast becoming the gold-standard in prostate cancer, both in staging of intermediate-/high-risk patients and in re-staging patients with biochemical failure. Several pitfalls of 18F-PSMA PET have been reported, and we report, to our best of knowledge, for the first time, a case which could have been falsely diagnosed as peritoneal spread. A 67-year-old patient with high-risk prostate cancer underwent staging with 18F-PSMA-1007 PET/CT (PSMA-PET/CT). PSMA-PET/CT revealed a histologically confirmed prostatic malignancy in the peripheral left zone. Unexpectedly, additional multiple highly PSMA-expressing intraabdominal formations were discovered. Based on apparent anatomic asplenia and a history of traumatic splenic rapture during childhood, a suspicion of post-traumatic splenosis was raised. For further non-invasive evaluation, a C-99 sulphur colloid scintigraphy with SPECT was conducted, confirming the presence of multiple functional ectopic splenic tissues. This is, to our best of knowledge, the first case utilising 18F-PSMA-1007-PET/CT and 99mTc-sulphur colloid SPECT to detect intraabdominal splenosis, highlighting the high potential of nuclear medicine in such trivial cases.

Sections du résumé

Background UNASSIGNED
18F-prostate specific membrane antigen (PSMA) PET is fast becoming the gold-standard in prostate cancer, both in staging of intermediate-/high-risk patients and in re-staging patients with biochemical failure. Several pitfalls of 18F-PSMA PET have been reported, and we report, to our best of knowledge, for the first time, a case which could have been falsely diagnosed as peritoneal spread.
Case presentation UNASSIGNED
A 67-year-old patient with high-risk prostate cancer underwent staging with 18F-PSMA-1007 PET/CT (PSMA-PET/CT). PSMA-PET/CT revealed a histologically confirmed prostatic malignancy in the peripheral left zone. Unexpectedly, additional multiple highly PSMA-expressing intraabdominal formations were discovered. Based on apparent anatomic asplenia and a history of traumatic splenic rapture during childhood, a suspicion of post-traumatic splenosis was raised. For further non-invasive evaluation, a C-99 sulphur colloid scintigraphy with SPECT was conducted, confirming the presence of multiple functional ectopic splenic tissues. This is, to our best of knowledge, the first case utilising 18F-PSMA-1007-PET/CT and 99mTc-sulphur colloid SPECT to detect intraabdominal splenosis, highlighting the high potential of nuclear medicine in such trivial cases.

Identifiants

pubmed: 39355050
doi: 10.3389/fnume.2023.1319952
pmc: PMC11440873
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Pagination

1319952

Informations de copyright

© 2023 Nearchou, Georgiou, Vrachimis, Ferentinos and Strouthos.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Marina Nearchou (M)

Department of Radiation Oncology, German Oncology Centre, University Hospital of the European University, Limassol, Cyprus.

Elizabeth Georgiou (E)

Department of Radiation Oncology, German Oncology Centre, University Hospital of the European University, Limassol, Cyprus.

Alexis Vrachimis (A)

Department of Nuclear Medicine, German Oncology Centre, University Hospital of the European University, Limassol, Cyprus.

Konstantinos Ferentinos (K)

Department of Radiation Oncology, German Oncology Centre, University Hospital of the European University, Limassol, Cyprus.

Iosif Strouthos (I)

Department of Radiation Oncology, German Oncology Centre, University Hospital of the European University, Limassol, Cyprus.

Classifications MeSH